Production and testing of the flat faced tablets via overprinting of injection moulded tablet bases
Abstract
Conventional drug production assures the merits of maintaining unit
dosage form accuracy, stable dose and invariability among the batches. It
also has a shortcoming that cannot make personalised medicine that could
target different individuals.
3D printing manufacturing technique allows for tailored dosage forms for
individual patients by providing precision medicine solutions; however, it’s
hard to scale up efficiently.
Injection moulding has been applied in the pharmaceutical area for a long
time. It is available for the high production of tablets, but when it’s involved
in personalised customisation, it’s neither cost-saving nor the simple making
of designed moulding tooling.
Overprinting is a proposed approach that combines the above two
techniques to tailor the personalised solid dosage forms. It means to
fabricate the injection moulded layer firstly then overprinting on the top of
the tablet. All of the processes and testing results were implemented and
presented.
The following license files are associated with this item: